Go to deals
Healthcare

CARSO Group has acquired Bactéries et Aliments

June 2025 — CARSO Group has strengthened its leadership in the food safety sector through the acquisition of Bactéries et Aliments.

Established in 1992 and headquartered in France, CARSO is one of the leading providers of analytical services in the French market, with operations in several neighboring countries. The company offers a broad range of analyses, including water and environmental testing, occupational hygiene and building health, food safety, genetic testing and pharmaceutical analysis. In 2021, ARCHIMED became CARSO’s majority shareholder, in partnership with CAPZA, Siparex, the management team and the company’s founders. Since then, ARCHIMED has supported CARSO’s organic and external growth across Europe through targeted acquisitions and strategic partnerships in high-potential market segments. The shared objective is to further strengthen CARSO’s position as an independent, entrepreneurial and international platform in the analytical services industry.

Founded over 20 years ago, Bactéries et Aliments is a laboratory specializing in microbiological analysis. It is recognized in the field of food hygiene for its customized services, expert guidance and cutting-edge R&D activities that support development projects within the food industry.

Our role in the transaction

Oaklins’ team in France advised CARSO and its shareholders on the acquisition of Bactéries et Aliments.

Parties

Talk to the deal team

Armelle Brossard Laborderie

Partner
Paris, France
Oaklins France

Océane Chainho

Associate Director
Paris, France
Oaklins France

Related deals

Indigo Capital has acquired a minority stake in Vivason
Private Equity | Consumer & Retail | Healthcare

Indigo Capital has acquired a minority stake in Vivason

Indigo Capital has acquired a minority stake in Vivason, a leading network of hearing care centers, to support the company’s growth and enable management to increase its ownership stake.

Learn more
Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more